# NATCO Pharma Limited – FDA Inspection, Jun 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/ea855f48-56a5-4020-95b4-2e58b1a8caf2
Source feed: FDA_Inspections

> FDA inspection 1095772 of NATCO Pharma Limited, June 06, 2019. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 7 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1095772
- Company Name: NATCO Pharma Limited
- Inspection Date: 2019-06-06
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1273711 - 2025-06-19](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/80aae95c-db8b-4043-b5c3-41597f602f4d)
- [FDA Inspection 1220533 - 2023-10-18](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/490eaf04-f2ac-48ef-96c9-2879ca06696c)
- FDA Inspection 1137171 - 2019-06-24
- [FDA Inspection 1011854 - 2017-01-24](https://www.keypedia.com/records/fda_inspections/natco-pharma-limited/6e9d6dc9-1872-4792-aa61-4d0ea396c351)
- FDA Inspection 880454 - 2014-05-23

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/marcellinus-d-dordunoo/a0e35c24-0cf5-4b11-95ba-1693fa3ecb3a)
- [Issuing Officer](https://www.keypedia.com/people/patric-c-klotzbuecher/cbb2e6b5-b001-457e-9073-33535f02926e)

Company: https://www.keypedia.com/companies/natco-pharma-limited/4c97e2d8-0023-4572-966f-d396e8fecc05

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
